Innovative startups, multinational corporations, and other IP-driven organizations turn to Finnegan for guidance when considering their IP options. We work with our client’s business, legal, marketing, and technical staffs to develop IP portfolios that align with their business objectives. Through our European, UK, and U.S. practices, we assess existing and developing portfolios to ensure that business plans are built on and around products based on strong IP protection that avoid infringement. This work often entails identifying and prioritizing assets with recommendations to license technologies or sell marginal assets to generate revenue, to donate or even abandon assets to reduce costs, and to identify acquisitions to strengthen or expand an existing portfolio.
Oversaw due diligence for one of the world’s largest chemical companies during the acquisition of another company, including overseeing the mapping and analysis of the target’s patent portfolio and analyzing potential infringement by competitors.
Webinar
Maximizing Benefits and Minimizing Risks in Open-Source Software Licensing
July 17, 2024
Webinar
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Webinar
January 11, 2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.